---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-239251"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:46:34.326502+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics shareholders reject liquidation and dissolution plan

## Summary
- Proposal to approve dissolution received 13,938,893 FOR and 18,075,579 AGAINST; not approved.
- Proposal to adjourn for additional proxy solicitation also failed: 14,036,711 FOR vs 17,977,422 AGAINST.
- Company has discontinued business activities and lacks resources; board to explore alternatives.
- Special meeting held October 17, 2024; 32,061,280 shares (58.94% of outstanding) represented.

## SEC filing metadata
- accession: 0001193125-24-239251
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312524239251/0001193125-24-239251-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312524239251/d899671d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-239251
- JSON: https://secwatch.observer/filing/0001193125-24-239251.json
- Plain text: https://secwatch.observer/filing/0001193125-24-239251.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.